Results 31 to 40 of about 7,093,593 (187)
Since 2007, a new class of biologic products for human use called “advanced therapy medicinal products (ATMP)” have been legally integrated in the European Medical Agency. They consist of recombinant nucleic acid, engineered cells, cells, or tissues.
Margaux Damerval +12 more
doaj +1 more source
Context-Aware Process Modelling for Medicinal Product Development [PDF]
Advanced Therapy Medicinal Products (ATMPs) are highly innovative medicinal products that are based on biomedical technology. ATMP development processes need to comply with complex regulatory frameworks.
Stirna, J. +7 more
core +1 more source
Background and aims The main causes of death in patients with severe Coronavirus disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan failure caused by a severe inflammatory cascade.
Morteza Zarrabi +21 more
doaj +1 more source
Magnetically Driven Biofabrication for Tissue Engineering: From Nanoparticle Design to Mag-ATMP Translation. [PDF]
Magnetically responsive nanoparticles enable remote control over biomaterials, cells, and engineered tissues. This review summarizes material design, biological safety, fabrication and actuation strategies, computational validation, and translational pathways that support the development of magnetic tissue‐engineering platforms and future magnetically ...
Ioannidis K +8 more
europepmc +2 more sources
Epidemiological and clinical studies have indicated an association between particulate matter (PM) exposure and acute and chronic pulmonary inflammation, which may be registered as increased mortality and morbidity.
Mahtab Tapak +3 more
doaj +1 more source
Recombinant PBP2a/autolysin conjugate as PLGA-based nanovaccine induced humoral responses with opsonophagocytosis activity, and protection versus methicillin-resistant Staphylococcus aureus infection [PDF]
Objective(s): Methicillin-resistant Staphylococcus aureus (MRSA) reasons extreme infections, can resist various conventional antimicrobial agents, and cause morbidity and mortality worldwide.
Setareh Haghighat +3 more
doaj +1 more source
Advanced Therapy Medicinal Products
125In recent years advances in biology, biotechnology, and medical research have led to a new category of biologicals – the advanced therapy medicinal products (ATMPs).
Dehmel, Susann +2 more
core +1 more source
Advanced therapy medicinal products: what's in a name? [PDF]
In this commentary I briefly discuss the term advanced therapy medicinal products (ATMPs). The last two words, medicinal products, correctly indicate that we are dealing with medicines.
Jiskoot, W.
core +1 more source
Candidiasis in breast cancer: Tumor progression or not? [PDF]
Candida albicans is an “opportunistic fungal agent” in cancer patients that can become colonized in both mucosal and deep tissues and cause severe infections. Most evidence has shown that C.
Somayeh Ashrafi +10 more
doaj +1 more source
Background Human dermal mesenchymal stromal cells (MSCs) expressing the ATP-binding cassette (ABC) efflux transporter ABCB5 represent an easily accessible MSC population that, based on preclinical and first-in-human data, holds significant promise to ...
Seda Ballikaya +15 more
doaj +1 more source

